Detalles de la búsqueda
1.
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.
Antimicrob Agents Chemother
; 68(4): e0119723, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376229
2.
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 65(12): e0089521, 2021 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516243
3.
Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745394
4.
Population Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Kinase Inhibitor, in Patients With Advanced Solid Tumors.
J Clin Pharmacol
; 62(3): 422-433, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34564871
5.
Population pharmacokinetic and exposure-response analyses from ALTA-1L: Model-based analyses supporting the brigatinib dose in ALK-positive NSCLC.
Clin Transl Sci
; 15(5): 1143-1154, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041775
6.
Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2.
Cancer Chemother Pharmacol
; 77(6): 1263-73, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27146400
Resultados
1 -
6
de 6
1
Próxima >
>>